Tibia nails |
Gentamicin |
Poly(D, L-lactide) with “dipcoating process” |
Clinical trial
|
[46,47] |
(Palacos R+G; Heraeus Medical, Wehrheim, Germany) |
Gentamicin |
Antibiotic -impregnated bone cement |
Clinical trial
|
[45] |
Titanium |
Vancomycin |
Poly(ethylene glycol) (PEG)-based hydrogel covalently bound to Ti |
Sustainable drug release (no initial burst release) In vivo rabbit model of S. aureus infection |
[44] |
Tialloy TiAl6V4 rods (Konigsee Implantate GmbH, Germany |
Gentamicin |
Plasma chemical oxidized |
In vivo rat osteomyelitis model S. aureus inoculum High prophylactic effect on implant-related osteomyelitis |
[48] |
PEEK implants |
Gentamicin |
LbL self-assembled |
Degradable multilayers that sequentially deliver the antibiotic and the osteoinductive growth factor (BMP-2). In vivo rat model infected with S. aureus
|
[50] |
Locking peg titanium |
Linezolid-rifampin |
Nanofiber coating by electrospun |
In vivo rabbit model of orthopedic implant-associated infection (OIAI) |
[49] |
Titanium |
Antimicrobial peptide (Melamine) |
Covalent bonding surface |
In vivo females mice with S. aureus and P. aeruginosa
|
[56] |
Tialloy |
Gentamicin |
Anodized Ti Nanotubes |
Controlled-antibiotic release. In vitro studies against S. aureus and P. aeruginosa. In vivo osteomyelitis rabbit model infected with S. aureus
|
[51–53] |